Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03113487
Title P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

MVAp53 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.